DK0865486T3 - Stabilt biotinyleret biomolekylepræparat og fremgangsmåder - Google Patents

Stabilt biotinyleret biomolekylepræparat og fremgangsmåder

Info

Publication number
DK0865486T3
DK0865486T3 DK96937005T DK96937005T DK0865486T3 DK 0865486 T3 DK0865486 T3 DK 0865486T3 DK 96937005 T DK96937005 T DK 96937005T DK 96937005 T DK96937005 T DK 96937005T DK 0865486 T3 DK0865486 T3 DK 0865486T3
Authority
DK
Denmark
Prior art keywords
methods
compositions
stable
biomolecule
protectant
Prior art date
Application number
DK96937005T
Other languages
English (en)
Inventor
Steven J Burton
James C Pearson
Peter A D Edwardson
Alan Menzies
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0865486T3 publication Critical patent/DK0865486T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08Radiation
    • A61L2/081Gamma radiation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
DK96937005T 1995-11-09 1996-10-24 Stabilt biotinyleret biomolekylepræparat og fremgangsmåder DK0865486T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/555,602 US6551794B1 (en) 1995-11-09 1995-11-09 Stable biotinylated biomolecule composition

Publications (1)

Publication Number Publication Date
DK0865486T3 true DK0865486T3 (da) 2006-02-06

Family

ID=24217905

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96937005T DK0865486T3 (da) 1995-11-09 1996-10-24 Stabilt biotinyleret biomolekylepræparat og fremgangsmåder

Country Status (13)

Country Link
US (1) US6551794B1 (da)
EP (1) EP0865486B1 (da)
JP (2) JP2000514778A (da)
AT (1) ATE312910T1 (da)
AU (1) AU717383B2 (da)
BR (1) BR9611430A (da)
CA (1) CA2237357C (da)
DE (1) DE69635584T2 (da)
DK (1) DK0865486T3 (da)
ES (1) ES2252761T3 (da)
IL (1) IL124375A (da)
NZ (1) NZ321443A (da)
WO (1) WO1997017435A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0868916A3 (en) * 1997-03-04 2004-09-15 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Reduction inhibitory agent for active-oxygen eliminating activity
CA2312476A1 (en) * 1997-12-09 1999-06-17 Bristol-Myers Squibb Company Fibrinogen-converting enzyme hybrids
US6187555B1 (en) 1998-04-16 2001-02-13 3M Innovative Properties Company Spores with increased sensitivity to sterilants using additives that bind to sterilant-sensitive sites
WO2001087357A2 (en) * 2000-05-17 2001-11-22 The American National Red Cross Gamma irradiation of protein-based pharmaceutical products
US6506365B1 (en) * 2000-09-25 2003-01-14 Baxter Aktiengesellschaft Fibrin/fibrinogen binding conjugate
US20030068416A1 (en) * 2001-09-24 2003-04-10 Wilson Burgess Method of lyophylization to reduce solvent content and enhance product recovery
US7319032B2 (en) * 2004-04-22 2008-01-15 Medtox Non-sugar sweeteners for use in test devices
EP1852443A1 (en) 2006-05-05 2007-11-07 Leukocare AG Biocompatible three dimensional matrix for the immobilization of biological substances
EP2058335B1 (en) * 2007-11-07 2020-06-24 Leukocare Ag Biocompatible three dimensional matrix for the immobilization of biological substances
US20160252434A1 (en) * 2014-04-16 2016-09-01 General Electric Company Gamma sterilized dextran solutions and methods of use
US20150299657A1 (en) * 2014-04-16 2015-10-22 General Electric Company Gamma stabilized dextran solutions and methods of use
RU2678828C2 (ru) * 2012-05-14 2019-02-04 Тейдзин Лимитед Белковая композиция, устойчивая к стерилизации облучением
CN103446600B (zh) * 2012-05-31 2020-05-22 通用电气公司 为含有葡萄糖氧化酶的膜杀菌的方法和相应的生物传感器
US20180055958A1 (en) 2015-03-12 2018-03-01 Sanyo Chemical Industries, Ltd. Method for producing protein composition, and protein composition
KR102774917B1 (ko) * 2018-05-18 2025-03-04 퀴아젠 사이언시스, 엘엘씨 방사선 멸균 또는 보관 기간 동안 생물학적으로 활성인 분자를 보호하는 방법
CN112852666A (zh) * 2021-01-19 2021-05-28 新疆河润水业有限责任公司 一种微生物菌剂的制备方法及采用微生物菌剂制备的微生物肥料

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3779706A (en) * 1971-10-04 1973-12-18 Energy Sciences Inc Process for bulk sterilization, minimizing chemical and physical damage
GB8331514D0 (en) 1983-11-25 1984-01-04 Janssen Pharmaceutica Nv Visualization method
JP2624470B2 (ja) 1984-10-02 1997-06-25 バイオジェン インコーポレイテッド ストレプトアビジン様ポリペプチドの製造
IL76234A0 (en) 1985-08-28 1986-01-31 Yeda Res & Dev New biotinylation reagents
US4806343A (en) * 1986-03-13 1989-02-21 University Of Southwestern Louisiana Cryogenic protectant for proteins
US4897346A (en) * 1986-07-15 1990-01-30 Beckman Instruments, Inc. Stabilized liquid enzyme composition for glucose determination
US4794082A (en) 1987-02-17 1988-12-27 Hoechst Celanese Corporation Biotinylating agents
US4709037A (en) 1987-02-17 1987-11-24 Hoechst Celanese Corporation Biotinylating agents
US4798795A (en) 1987-02-17 1989-01-17 Hoechst Celanese Corporation Biotinylating agents
JPS63246382A (ja) 1987-04-02 1988-10-13 Karupisu Shokuhin Kogyo Kk ビオチニル試薬及びそれを用いるビオチニル化法
US5043288A (en) 1988-06-20 1991-08-27 Motsenbocker Marvin A Immobilize molecular binding partners to contact activating supports
FR2638099B1 (fr) 1988-10-20 1991-01-25 Immunotech Sa Immunoadsorbant a faible taux de relargage et son procede d'obtention
US4897364A (en) 1989-02-27 1990-01-30 Motorola, Inc. Method for locos isolation using a framed oxidation mask and a polysilicon buffer layer
US5026785A (en) 1989-05-12 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Avidin and streptavidin modified water-soluble polymers such as polyacrylamide, and the use thereof in the construction of soluble multivalent macromolecular conjugates
JPH05331071A (ja) * 1992-01-17 1993-12-14 Asahi Chem Ind Co Ltd カルシトニン遺伝子関連ペプチド類の凍結乾燥組成物および安定化法
US5306824A (en) 1992-04-15 1994-04-26 Georgia Tech Research Corporation Biotinylated isocoumarins
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
JP3007785B2 (ja) * 1993-03-16 2000-02-07 旭化成工業株式会社 トロンボモジュリン組成物およびその変性防止方法
EP0731834B1 (en) 1993-12-03 2000-05-24 Buckman Laboratories International, Inc. Enzyme stabilization by block-copolymers
JPH07194378A (ja) 1993-12-28 1995-08-01 Fuji Seito Kk トレハロースによる酵素の安定化法
US5556771A (en) 1995-02-10 1996-09-17 Gen-Probe Incorporated Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification
WO1997011183A1 (en) * 1995-04-11 1997-03-27 Trustees Of Boston University Streptavidin mutants
US5691152A (en) * 1995-11-09 1997-11-25 E. R. Squibb & Sons, Inc. Stable avidin composition

Also Published As

Publication number Publication date
ES2252761T3 (es) 2006-05-16
DE69635584D1 (de) 2006-01-19
IL124375A0 (en) 1998-12-06
DE69635584T2 (de) 2006-09-21
IL124375A (en) 2002-04-21
EP0865486A4 (en) 2002-06-26
JP2000514778A (ja) 2000-11-07
JP2007295936A (ja) 2007-11-15
NZ321443A (en) 2000-01-28
EP0865486A1 (en) 1998-09-23
AU717383B2 (en) 2000-03-23
BR9611430A (pt) 1999-06-29
CA2237357C (en) 2002-07-30
WO1997017435A1 (en) 1997-05-15
EP0865486B1 (en) 2005-12-14
AU7477796A (en) 1997-05-29
US6551794B1 (en) 2003-04-22
ATE312910T1 (de) 2005-12-15
CA2237357A1 (en) 1997-05-15

Similar Documents

Publication Publication Date Title
DK0865486T3 (da) Stabilt biotinyleret biomolekylepræparat og fremgangsmåder
WO1995009821A3 (en) Improved cement admixture product having improved rheological properties and process of forming same
CA2227901A1 (en) Improved cement admixture product
CA2405716A1 (en) Chemically modified novel erythropoietin stimulating protein compositions and methods
MY112575A (en) Improved cement admixture product having improved rheological properties and process of forming same.
CA2273064A1 (en) Novel processes for amplifying nucleic acid, post-termination labeling process for nucleic acid sequencing and producing nucleic acid having decreased thermodynamic stability
DE60040980D1 (de) Chemisch veränderte, lipolytische enzyme
AU3349695A (en) Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof
GB2337051A (en) Process for making maleic anhydride polymers which include maleamic acid and/or its cyclic imide repeat units
NO992167D0 (no) Preparater og fremgangsmÕter for immobilisering av nukleinsyrer til faste bµrere
WO2002010231A3 (en) Polymeric compositions for forming optical waveguides; optical waveguides formed therefrom; and methods for making same
EP1306388A3 (en) Novel cellulose-producing bacteria
WO2001021760A3 (en) Cell culture spinner flasks
AU2831900A (en) Stereocomplex hydrogels
WO2001085800A3 (en) Esterified polysaccharide products and η-lactone ring opened ketene dimer products containing the compositions, and process of making the same
AU3101300A (en) Compositions containing alpha-sulfofatty acid esters and methods of making and using the same
AU5297999A (en) Use of a composition
ATE87429T1 (de) Verfahren zur herstellung von polysaccharide enthaltenden neuen getrockneten zusammenstellungen.
ES2181897T3 (es) Composicion enzimatica.
AU2787400A (en) Compositions and methods for modulating growth or differentiation of growth-factor dependent cells
NO974545L (no) Eksopolysakkaridnedbrytende enzym, og anvendelse av samme
IL137247A0 (en) Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
ATE211002T1 (de) Dextrinhaltige mischung zur verhinderung von chirurgischen verklebungen
ATE307494T1 (de) Zusammensetzung, welche pektinmethylesterase und zwei substrate beinhaltet
ATE222285T1 (de) Verwendung von polyamin-scavenger in enzyme enthaltenden waschmittelzusammensetzungen